Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by Ohio State University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
David O'Malley, The Ohio State University
ClinicalTrials.gov Identifier:
NCT00513786
First received: August 8, 2007
Last updated: May 3, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)